Jazz Pharmaceuticals plc announced that Samantha Pearce, Senior Vice President (SVP), Europe and International, has been promoted to Chief Commercial Officer (CCO) effective August 1, 2024. Ms. Pearce joined Jazz as SVP, Europe and International, in 2020, and brings more than 30 years of commercial experience in the pharmaceutical industry. Since joining Jazz, she has instilled a commitment to a high-performance culture, growing Jazz's commercial brands and harnessing the potential of Jazz's European and International business to provide transformative medicines for patients in more than 50 countries.

In her role as Chief Commercial Officer, she will be responsible for strategy and execution for Jazz's commercial business across all global markets and will be based in the U.S. From March 2010 to December 2019, Ms. Pearce held general management positions across an increasing breadth of global markets with Celgene Corporation, most recently as vice president and general manager of international markets. Prior to that, from August 2002 to March 2010, she served in commercial management positions at AstraZeneca plc, culminating in her role as director of specialist care. Prior to August 2002, she worked for DuPont Pharmaceuticals.

Ms. Pearce received a B.Sc. from Birmingham University, U.K. and an M.B.A. from Cranfield University, U.K.